Catheter ablation of ventricular tachycardia: strategies to improve outcomes

• Published in: Frontiers in cardiovascular medicine Vol. 10; p. 966634
• Main Authors: Subramanian, Muthiah, Atreya, Auras R., Saggu, Daljeet Kaur, Yalagudri, Sachin, Calambur, Narasimhan
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 14.08.2023
• Subjects: Cardiovascular Medicine; catheter ablation; electro-anatomic mapping; improving VT ablation; substrate mapping; ventricular tachycardia
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2023.966634

Catheter ablation of ventricular arrhythmias has evolved considerably since it was first described more than 3 decades ago. Advancements in understanding the underlying substrate, utilizing pre-procedural imaging, and evolving ablation techniques have improved the outcomes of catheter ablation. Ensuring safety and efficacy during catheter ablation requires adequate planning, including analysis of the 12 lead ECG and appropriate pre-procedural imaging. Defining the underlying arrhythmogenic substrate and disease eitology allow for the developed of tailored ablation strategies, especially for patients with non-ischemic cardiomyopathies. During ablation, the type of anesthesia can affect VT induction, the quality of the electro-anatomic map, and the stability of the catheter during ablation. For high risk patients, appropriate selection of hemodynamic support can increase the success of VT ablation. For patients in whom VT is hemodynamically unstable or difficult to induce, substrate modification strategies can aid in safe and successful ablation. Recently, there has been an several advancements in substrate mapping strategies that can be used to identify and differentiate local late potentials. The incorporation of high-definition mapping and contact-sense technologies have both had incremental benefits on the success of ablation procedures. It is crucial to harness newer technology and ablation strategies with the highest level of peri-procedural safety to achieve optimal long-term outcomes in patients undergoing VT ablation.